[favorable policies driving the development of agglomeration industry]
Since the 21st century, the era of bio economy has become the next era of revolutionary industrial economy after the era of information economy. As one of China's strategic emerging industries and pillar industries of national economy, the development of bio industry is highly valued by our government. In 2016, the State Council issued the 13th five year plan for national science and technology innovation, which proposed the development of advanced and efficient biotechnology, focusing on the innovative breakthrough and application development of Frontier biotechnology. In 2017, the national development and Reform Commission issued the 13th five year plan for the development of biological industry, which further put forward specific plans for the development of biological industry. With the introduction of a series of policies and implementation rules, the agglomeration effect of China's biological industry development has gradually improved, and the spatial layout of three comprehensive biological industry bases and several professional biological industry bases in the Yangtze River Delta, Guangdong, Hong Kong, Macao and Beijing Tianjin Hebei region has begun to take shape.
Relying on the existing industrial and regional resource base, the 6th Guangzhou International Biotechnology conference will be held in the exhibition hall of Guangzhou Canton Fair from September 10 to 12, 2020.
[upgrade bte2021 again]
As a highly recommended professional platform in South China, BTE Guangzhou International Biotechnology conference, in promoting the construction of Guangdong, Hong Kong and Macao Bay area, is building a high-level scientific and technological innovation carrier and platform around the collaborative development, exchange and integration of biological industry clusters in Guangdong, Hong Kong and Macao Bay area.
In order to better take the docking of supply and demand as the breakthrough point, promote the local biological enterprises to strengthen the cooperation of industrial chain, propose to build a complete industrial chain and create industrial clusters. Bte2021 will comprehensively upgrade on the basis of traditional expositions, focus on the efficient integration of technology application and theory in the form of "meeting and leading exhibition", and focus on demonstrating the innovation ability and industrialization level of biotechnology industry. It is estimated that the scale will reach 200 + well-known exhibitors at home and abroad, 10000 + professional visitors, 60 + Summit Forum, 60 + speakers and 15000 + exhibition area.
[innovate digital exhibition mode and create precision trade platform]
BTE now relies on the mature exhibition experience of Zhenwei exhibition and the huge customer resources of related themes, and on the basis of professional authority, it upgrades, integrates and innovates again, and introduces a series of solutions of "online offline linkage, exhibition on the cloud", covering all-weather online virtual display, online promotion, online negotiation, supply and purchase docking, conference live broadcast, marketing activities, all network publicity, etc aspect.
At the same time, combined with the Internet, big data, artificial intelligence and other advanced information technology, the company will unite suppliers, purchasers and exhibition visitors to build a purchasing and trading platform combining online and offline, so as to achieve accurate docking with customers and promote efficient business trade.
[leading enterprises focus on industry frontier development]
Guangzhou International Biotechnology conference has been successfully held for five times. Through the construction of the platform over the years, it has formed a technology information exchange platform with complete functions, outstanding technical advantages, complete information and strong innovation ability.
Thermofisher, Merck, unchained labs, bio bad, Shimadzu, Sony, BD, Fujifilm, keenss, applied light, Saiye biology, saixintong, Roche Diagnostics, macaudi, lanfan medical, Jiete biology, Sanyou biology, Zhongke duling, Luminex, Guangdong Yaokang, burning stone medicine, Yisheng biotechnology, SCIEX China, Beijing quanshijin, Hongxun technology, Sanyou Well known exhibitors at home and abroad, such as biology, colpalmer, Luminex, Vittoria, have joined hands to promote the high-end, large-scale and intensive development of biological industry.
[Summit Forum gathering think tanks to seek the road of industry development]
Bte2021 will invite dozens of summit forums from authoritative experts of national government agencies, top executives of pharmaceutical enterprises and biotechnology companies at home and abroad to share the latest industry information such as policy demand, technological research, industrial planning and market management, aiming to focus on the latest development of technologies in frontier hot fields such as biological antibodies, immunotherapy, innovative drugs, diagnostic medicine, biological manufacturing and vaccine research New progress, combined with the current Guangdong, Hong Kong and Macao Bay District to promote the development of Biomedical Innovation of a number of good new policies, to explore the current hot spots of the biological industry, study and judge the future trend, and seek common development path.
Bte2021 conference theme
Antibody drugs and new drug development
Targeting and cellular immunotherapy
In vitro diagnosis and future medicine
Innovation and development of biological similar drugs
Conference on vaccine research and innovation
New drug application and cro / CMO
Laboratory construction and innovation
Process control and solution of biological products
微生物技术与生物制?

Event topics
Forum on R & D and innovation of antibody drugs and new drugs
The past, present and future of monoclonal antibody coupled (ADC) drugs
Domestic development of anti-tumor monoclonal antibodies
Research and development of new neutralizing antibody project
Whole human antibody drug development and difficulties
Antibody drug discovery based on a new generation of core technology platform
Designing new strategies for tumor immunotherapy from the mechanism of non response to PD1 / PD-L1 inhibitors
Development and exploration of downstream purification process of antibody drugs
Discussion on construction of stable cell line and technology development strategy
Innovative bispecific antibody development
In vitro diagnostic industry development forum
Comparison of new coronavirus diagnosis and detection methods
Application of nucleic acid mass spectrometry detection and analysis technology in precision medicine
New progress and clinical practice of molecular diagnosis technology
Digital PCR technology and its research progress in molecular diagnosis
Explore the future of artificial intelligence and accurate diagnosis
Hypersensitive detection of PD-L1 protein in peripheral blood and its application
Application of DNA hydroxymethylation detection in liquid biopsy
Targeting and cellular immunotherapy
Progress and development trend of cell therapy technology at home and abroad
U.S. FDA's regulatory thinking on cell gene therapy products and Its Enlightenment to China
The strategy of combined immunotherapy for solid tumors from clinical trials
Research and development, technology and clinical progress of cell therapy
New tumor immunotherapy technology / emerging targeted therapy / PD-L1 therapy technology
Immunotherapy: immune checkpoint blocking therapy, new generation of gene modified cell therapy
Treatment of solid tumor / immunotherapy combined with other methods
Innovation and development of biological similar drugs
The latest requirements of clinical review regulations for biological similar drugs at home and abroad
Current situation and trend of research and development of biological similar drugs in China
Development and application of biosimilars
Development and process optimization of biological similar drugs
Development and clinical application of biological analogues
Key issues of particle size analysis in consistency evaluation of biological similar drugs
Conference on vaccine research and innovation
Policy interpretation of "vaccine management law"
Global R & D Progress of new crown vaccine
New vaccine discovery, concurrency and design
Vaccine delivery research
Vaccine cGMP process development and quality control
Current situation of tumor vaccine research and development
New drug application and cro / CMO
Trend and business pattern of pharmaceutical cro industry
Interpretation of the relevant stimulating and supporting policies to promote the development of cro industry under China's 14th five year plan
Case analysis of clinical development of monoclonal antibody drugs
Preclinical safety evaluation in biomedical research and development
Risk monitoring of clinical trials
Status and trend of CMO in Biopharmaceuticals
Transparent production of CMO to ensure product quality
Application of single use system in biopharmaceutical CMO
Full life cycle CMO management

Laboratory technology and equipment
Cell culture system, biochemical analysis instrument, biological imaging system, biochip, HPLC, separation and purification system, reagents, accessories and consumables, laboratory information management system, GLP / GMP, disinfection and clean room equipment, etc.
Laboratory technology and equipment
Cell culture system, biochemical analysis instrument, biological imaging system, biochip, HPLC, separation and purification system, reagents, accessories and consumables, laboratory information management system, GLP / GMP, disinfection and clean room equipment, etc.
Biotechnology services
Gene detection, stem cell technology, microbiology, molecular biology, cell biology services, biochip services, cro / CMO, technical training services, immunology services, staffing services and other contract services.
Medical laboratory and IVD
Biochemical diagnosis, immune diagnosis, molecular diagnosis, microbiological diagnosis, urine diagnosis, cytological diagnosis, POCT and other fields of diagnostic instruments, diagnostic reagents, auxiliary equipment and supplies.
Engineering equipment
Fermentation tank, cell reactor, cell culture equipment, saccharification equipment, separation and filtration, extraction and purification, instrumentation and industrial automation equipment, sanitary fluid equipment, environmental protection technology and equipment, etc.
Quality control and safety
Quality management analysis, particle measurement equipment, comprehensive evaluation system, sugar chain / carbohydrate analysis system, viscometer, stability evaluation equipment, amino acid analysis system, etc.
Biopharmaceutical ingredients
Biopharmaceutical raw materials, APIs, enzymes, auxiliary materials, additives, stabilizers, test kits, antibodies, starch sugars and glycols, yeast and its derivatives, amino acids and organic acids and natural extracts, etc.

Advertising expenses

the measure of area: 10000 square meters

• Telephone:020-83953215
• Truename:Gong man
• Mobile:13710163299
• Fax:020-83953200
• E-mail:2850965539@qq.com
• QQ:2850965539
• Address:Room 403, Qisheng exhibition Industrial Park, 2433 Xingang East Road, Haizhu District, Guangzhou

The information on this site comes from the network and related members, and the website has done its duty to review it. Due to the uncontrollability of the process of organizing the exhibition, some of the exhibition information in the station may change the subject matter, Extending or cancelling the event, please exhibitors and visitors must check with each other again before exhibiting! All the exhibitions in this site are not hosted/co-organized or organized, if there are any disputes during the exhibition, please hold the main responsibility of the exhibition organization! QQ Email: 523138820@qq.com WeChat: 523138820 Mobile: 15313206870